Association of apolipoprotein E polymorphism with ischemic stroke subtypes in Taiwan

Kaohsiung Journal of Medical Sciences

Volumn 23, Issue 10, 2007, Pages 491-497

  Lai, Chiou Lian ^a,b   Liu, Ching Kuan ^b,c   Lin, Ruey Tay ^b,c   Tai, Chih Ta ^b,c  

^a KAOHSIUNG MUNICIPAL HSIAO KANG HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Apolipoprotein E; Ischemic stroke; Taiwan

Indexed keywords

APOLIPOPROTEIN E;

ADULT; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; GENE FREQUENCY; GENOTYPE; HEREDITY; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; TAIWAN;

EID: 36049044523     PISSN: 1607551X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1607-551X(08)70006-8     Document Type: Article

References (42)

1. Khaw KT. Epidemiology of stroke. J Neurol Neurosurg Psychiatry 1996;61:333-8.
2. Kanter MC, Sherman DG. Strategies for preventing stroke. Curr Opin Neurol Neurosurg 1993;6:60-5.
3. Kokubo Y, Chowdhury AH, Date C, et al. Age-dependent association of apolipoprotein E genotypes with stroke subtypes in a Japanese rural population. Stroke 2000;31:1299-306.
4. Sacco RL, Kargman DE, Gu O, Zamanillo MC. Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction: the northern Manhattan stroke study. Stroke 1995;26:4-20.
5. Davis LE, Xie JG, Zou AH, et al. Deep cerebral infarcts in the People's Republic of China. Stroke 1990;21:394-6.
6. Feldmann E, Daneault N, Kwan E, et al. Chinese-white difference in the distribution of occlusive cerebrovascular disease. Neurology 1990;40:1541-5.
7. Weusberg LA. Lacunar infarcts. Clinical and computed tomographic correlation. Arch Neurol 1982;39:37-40.
8. Iso H, Jacobs DR Jr, Wentworth D, et al. Serum cholesterol levels and six year mortality from stroke in 350,977 men screened for the Multiple Risk Factor Interventional Trial. N Engl J Med 1989;320:722-40.
9. Luthra K, Prasad K, Kumar P, et al. Apolipoprotein E gene polymorphism in cerebrovascular disease: a case-control study. Clin Genet 2002;62:39-44.
10. Mahley RW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 1998;240:622-30.
11. de Knijft P, van den Maagdenberg AMJM, Frants R, et al. Genetic heterogeneity of apolipoprotein E and its influence on plasma lipid and lipoprotein levels. Hum Mutat 1994;4:178-94.
12. Pedro-Botet J, Senti M, Nogues X, et al. Lipoprotein and apolipoprotein profile in men with ischemic stroke. Stroke 1992;23:1556-62.
13. Couderc R, Mahieux F, Bailleul S, et al. Prevalence of apolipoprotein E phenotypes in ischemic cerebrovascular disease. A case-control study. Stroke 1993;24:661-4.
14. Kuusisto J, Mykkanen L, Kervinen K, et al. Apolipoprotein E4 phenotype is not an important risk factor for coronary heart disease or stroke in elderly subjects. Arterioscler Thromb Vasc Biol 1995;15:1280-6.
15. Hifuchi S, Arai H, Nakagawa T, et al. The apolipoprotein E gene in Binswanger's disease and vascular dementia. Clin Genet 1996;50:459-61.
16. Basun H, Corder EH, Guo Z, et al. Apolipoprotein E polymorphism and stroke in a population sample aged 75 years or more. Stroke 1996;27:1310-5.
17. Marin DB, Brenda B, Marin ML, et al. The relationship between apolipoprotein E, dementia, and vascular illness. Atherosclerosis 1998;140:173-80.
18. Slooter AJC, Bots ML, Havekes LM, et al. Apolipoprotein E and carotid artery atherosclerosis. The Rotterdam study. Stroke 2001;32:1947-52.
19. Topic E, Simundic AM, Stefanovic M, et al. Polymorphism of apolipoprotein E (APOE), methylenetetrahydrofolate reductase (MTHFR) and paraoxonase (PON1) genes in patients with cerebrovascular disease. Clin Chem Lab Med 2001;39:346-50.
20. Bachman DL, Wolf PA, Linn RT, et al. Prevalence of dementia and probable senile dementia of the Alzheimer's type in the Framingham study. Neurology 1992;42:115-9.
21. Duara R, Barker WW, Lopez-Alberola R, et al. Alzheimer's disease: interaction of apolipoprotein E genotype, family history of dementia, gender, education, ethnicity, and age of onset. Neurology 1996;46:1575-9.
22. Mak YT, Chiu H, Woo J, et al. Apolipoprotein E genotype and Alzheimer's disease in Hong Kong elderly Chinese. Neurology 1996;46:146-9.
23. Hong CJ, Liu TY, Liu HC, et al. ε4 allele of apolipoprotein E increases risk of Alzheimer's disease in a Chinese population. Neurology 1996;46:149-75.
24. Katzman R, Zhang MY, Chen PJ, et al. Effects of apolipoprotein E in dementia and aging in the Shanghai survey of dementia. Neurology 1997;49:779-85.
25. Kim HC, Kim DK, Choi IJ, et al. Relation of apolipoprotein E polymorphism to clinically diagnosed Alzheimer's disease in the Korean population. Psy Clin Neurosci 2001;55:115-20.
26. Hallman DM, Boerwinkle E, Saha N, et al. The Apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations. Am J Hem Genet 1991;49:338-49.
27. Eggertsen G, Tegelman R, Ericsson S, et al. Apolipoprotein E polymorphism in a healthy Swedish population: variation of allele frequency with age and relation to serum lipid concentrations. Clin Chem 1993;39:2125-9.
28. Gerdes LU, Klausen LC, Sihm I, et al. Apolipoprotein E polymorphism in a Danish population compared to findings in 45 other study populations around the world. Genet Epidemiol 1992;9:155-67.
29. Liu HC, Hong CJ, Wang SJ, et al. ApoE genotype in relation to AD and cholesterol: a study of 2,326 Chinese adults. Neurology 1990;59:962-6.
30. Special Report from the National Institute of Neurological Disorders and Stroke. Classification of Cerebrovascular Diseases III. Stroke 1990;21:637-76.
31. Wenham PR, Price WH, Blandell G. Apolipoprotein E genotyping by one-stage RCR. Lancet 1991;337:1158-9.
32. Hixson JE. Apolipoprotein E polymorphisms affect atherosclerosis in young males. Pathobiological determinants of atherosclerosis in Youth (PDAY) research group. Arterioscler Thromb Vasc Biol 1991;11:1237-44.
33. Fisher CM. Lacunar strokes and infarcts: a review. Neurology 1990;32:871-6.
34. He J, Klag MJ, Wu Z, Whelton PK. Stroke in the People's Republic of China. Stroke 1995;26:2222-7.
35. Horowitz DR, Tuhrim S, Weinberger JM, et al. Mechanisms in lacunar infarction. Stroke 1992;23:325-7.
36. Zannad F, Visvikis S, Gueguen R, et al. Genetics strongly determines the wall thickness of the left and right carotid stenosis. Hum Genet 1998;103:183-8.
37. Caplan LR, Gorelick PB, Hier DB. Race, sex and occlusive cerebrovascular disease: a review. Stroke 1986;17:648-55.
38. Shimano H, Ishibashi S, Murase T, et al. Plasma lipoprotein in patients with multi-infarct dementia. Atherosclerosis 1989;79:257-60.
39. Martins IJ, Hone E, Foster JK, et al. Apolipoprotein E, cholesterol metabolism, diabetes, and the convergence of risk factors for Alzheimer's disease and cardiovascular disease. Mol Psychiat 2006;11:721-36.
40. Du L, Du Y, Huang X. Association of apolipoprotein E gene polymorphism with essential hypertension and its complication. Clin Exp Med 2003;2:175-9.
41. von Reuten GM, von Budingen HJ. Ultrasound Diagnosis of Cerebrovascular Disease. New York: Georg Thieme, 1993.
42. Schultz UGR, Rothwell PM. Differences in vascular risk factors between etiological subtypes of ischemic stroke. Importance of population-based studies. Stroke 2003;34:2050-9.